Treatments

Transcranial Magnetic Stimulation (TMS) has been cleared or approved by the FDA or European CE for the following conditions (as of early 2024)

1. 1. Major Depressive Disorder (MDD)
   • FDA: Approved for treatment-resistant depression (since 2008).
   • CE: Approved for MDD.


2. 2. Obsessive-Compulsive Disorder (OCD)
   • FDA: Cleared for OCD (2018, via Brainsway Deep TMS™).
   • CE: Approved for OCD.


3. 3. Migraine with Aura
   • FDA: Cleared for acute treatment (2013, eNeura sTMS device).


4. 4. Smoking Cessation (Short-Term Aid)
   • FDA: Cleared as an adjunct for short-term smoking cessation (2020, Brainsway Deep TMS™).


5. 5. Neuropathic Pain
   • CE: Approved for chronic neuropathic pain management.


6. 6. Parkinson’s Disease (Motor Symptoms)
   • CE: Approved to address motor symptoms (e.g., bradykinesia, rigidity).


7. 7. Stroke Rehabilitation (Motor Recovery)
   • CE: Approved for post-stroke motor recovery.


8. 8. Tinnitus
   • CE: Approved for chronic subjective tinnitus.


9. 9. Schizophrenia (Negative Symptoms)
   • CE: Approved for managing negative symptoms (e.g., apathy, social withdrawal).

Apart from the approved conditions, TMS can also be used off-label for various other conditions, such as:

• • Anxiety Disorders, such as Generalized Anxiety, or Phobia
• • Refractory Auditory Hallucinations
• • Alzheimer’s Dementia
• • And many others, using a case-by-case, collaborative decision-making process.